Showmenu

Thomas Luh, M.D. for UC Davis Health

Thomas  Luh, M.D.

Thomas Luh, M.D.

Associate Physician

To see if Thomas Luh is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Specialties

Internal Medicine

Hospital Medicine

Department

Internal Medicine

Locations and Contact

UC Davis Medical Center

UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Philosophy of Care

I believe excellent hospital care begins with truly understanding what matters to each patient and family before making decisions together. Every person deserves open, honest communication and partnership with their medical team for support through a vulnerable time.

Clinical Interests

Dr. Luh is an internal medicine physician who provides care for adult hospitalist patients. He has particular interest in medical education and point of care ultrasound.

Research/Academic Interests

Dr. Luh’s research focuses on chronic obstructive pulmonary disease (COPD) population health with a data science approach.

Division

Hospital Medicine

Undergraduate School

B.A., Biochemistry, Columbia University, 2018

Medical School

M.D., UCSF, 2023

Internship

Internal Medicine, UC Davis, 2023-24

Residency

Internal Medicine, UC Davis, 2024-26

Graduated Magna Cum Laude from Columbia University, 2018,

2023. Liu K, Lee J, Luh T. Clonal Analysis of Human Dendritic Cell Progenitors Using a Stromal Cell Culture,

Methods Mol Biol.

2018. Luh T, Lucero K, Ma W, Lee J, Zhou YJ, Shen Y, Liu K. High Dimensional Functionomic Analysis of

Human Hematopoietic Stem and Progenitor Cells at a Single Cell Level, Bio-Protocol.

2017. Lee J, Zhou YJ, Ma W, Zhang W, Aljoufi A, Luh T, Lucero K, Liang D, Thomsen M, Bhagat G, Shen Y,

Liu K. Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem

cells and multipotent progenitors, Nat Immunol

2017. Chock VY, Goel VV, Palma JP, Luh TM, Wang NA, Gaskari S, Punn R, Silverman NH, Benitz WE.

Changing Management of the Patent Ductus Arteriosus: Effect on Neonatal Outcomes and Resource

Utilization, Am J Perinatol

2016. Li H, Yue D, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, Zhang Z,

Zhou Y, Wang L, Hao X, Jablons D, Wang C, He B. Gli promotes epithelial-mesenchymal transition in

human lung adenocarcinomas, Oncotarget

2015. Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh T,

Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B. EMX2 is a

predictive marker for adjuvant chemotherapy in lung SCC, PLOS ONE

2014. Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, Shi H,

Zhang H, Hao X, Wang C, Jablons DM, He B. Hedgehog/Gli promotes epithelial-mesenchymal transition in

lung SCC, JECCR

2013. Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons

DM, He B. Gli as a novel therapeutic target in malignant pleural mesothelioma, PLOS ONE